-
公开(公告)号:US20150031621A1
公开(公告)日:2015-01-29
申请号:US14327110
申请日:2014-07-09
申请人: OCTAPHARMA AG
IPC分类号: C07K14/47
CPC分类号: C07K14/472 , A61K38/1709 , C07K1/36 , C07K14/435 , C07K14/47
摘要: A method for purification of complement Factor H from a complement Factor H containing source such as blood or blood plasma, in particular a caprylate precipitate of a Factor H containing source, which is e.g. obtained by addition of caprylate ions to fractions of blood or plasma, comprising the steps of: a) providing a Factor H containing source, in particular reconstitution of caprylate precipitate to provide a complement Factor H containing solution; b) performing a cation exchange chromatography in particular as first chromatographic step; c) performing an anion exchange chromatography; d) performing a hydroxyl apatite chromatography; e) followed by ultra/diafiltration to obtain a complement Factor H concentrate.
摘要翻译: 用于从补体因子H纯化补体因子H的方法,所述补体因子H含有血液或血浆中的源,特别是含H因子的来源的辛酸盐沉淀物。 通过向血液或血浆的级分中加入辛酸盐离子获得,包括以下步骤:a)提供含有因子H的来源,特别是辛酸沉淀重构以提供补体因子H的溶液; b)特别是进行阳离子交换层析作为第一色谱步骤; c)进行阴离子交换层析; d)进行羟基磷灰石层析; e),然后进行超/渗滤以获得补体因子H浓缩物。